Lotus Eye Hospital and Institute Limited
NSE:LOTUSEYE.NS
69.89 (INR) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||
Current Assets: | ||||||||||||||
Cash & Cash Equivalents
| 70.404 | 36.03 | 37.889 | 51.807 | 44.682 | -2.264 | 0.216 | 49.847 | 24.737 | 5.155 | 9.201 | 23.272 | 2.067 | 8.354 |
Short Term Investments
| 43.878 | 48.11 | 50.041 | 47.117 | 25.274 | 28.193 | 37.908 | 41.921 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 70.404 | 84.14 | 87.93 | 98.924 | 69.956 | 25.929 | 38.124 | 49.847 | 24.737 | 5.155 | 9.201 | 23.272 | 2.067 | 8.354 |
Net Receivables
| 12.578 | 11.721 | 6.749 | 7.618 | 15.916 | 18.434 | 11.407 | 13.912 | 5.1 | 3.531 | 3.942 | 3.093 | 59.026 | 0 |
Inventory
| 32.116 | 27.906 | 23.053 | 17.795 | 21.128 | 21.554 | 23.89 | 17.983 | 27.812 | 30.852 | 36.372 | 31.494 | 21.01 | 16.649 |
Other Current Assets
| 25.073 | 23.334 | 10.889 | 11.703 | -0.001 | -0.001 | 18.872 | 1.8 | 10.279 | 20.688 | 20.586 | 20.131 | 0.585 | 116.436 |
Total Current Assets
| 140.171 | 147.101 | 128.621 | 136.04 | 106.999 | 65.916 | 80.886 | 83.542 | 62.828 | 56.695 | 66.159 | 74.897 | 82.688 | 141.439 |
Non-Current Assets: | ||||||||||||||
Property, Plant & Equipment, Net
| 486.54 | 440.746 | 439.496 | 403.749 | 424.432 | 442.323 | 425.754 | 417.747 | 437.221 | 472.602 | 472.321 | 453.689 | 0 | 482.685 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.001 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.744 | 1.015 | 1.228 | 1.631 | 2.186 | 1.972 | 2.275 | 1.994 | 2.705 | 0.538 | 0.712 | 1.172 | 0 | 0 |
Goodwill and Intangible Assets
| 0.744 | 1.015 | 1.228 | 1.631 | 2.186 | 1.972 | 2.275 | 1.994 | 2.706 | 0.538 | 0.712 | 1.172 | 0 | 0 |
Long Term Investments
| 0 | 9.5 | 0 | 0 | -23.665 | -27.854 | -37.679 | 42.712 | -2.706 | -0.538 | 0 | 0 | 0 | 0 |
Tax Assets
| 3.045 | 3.844 | 5.23 | 7.733 | 8.496 | 10.002 | 8.013 | 1.962 | 1.532 | 0.32 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 35.767 | 29.674 | 41.393 | 43.138 | 65.987 | 74.137 | 102.87 | -0.002 | 46.707 | 34.534 | 46.349 | 39.198 | 477.801 | 2.01 |
Total Non-Current Assets
| 526.096 | 484.779 | 487.347 | 456.251 | 477.436 | 500.58 | 501.233 | 464.413 | 485.46 | 507.456 | 519.382 | 494.059 | 477.801 | 484.695 |
Total Assets
| 666.267 | 631.88 | 615.968 | 592.291 | 584.435 | 566.496 | 582.119 | 547.955 | 548.288 | 564.151 | 585.541 | 568.956 | 560.489 | 626.134 |
Liabilities & Equity: | ||||||||||||||
Current Liabilities: | ||||||||||||||
Account Payables
| 34.563 | 31.499 | 31.87 | 28.307 | 30.694 | 30.509 | 39.208 | 25.975 | 25.95 | 31.831 | 53.931 | 37.396 | 33.81 | 0 |
Short Term Debt
| 4.218 | 4.783 | 5.676 | 2.628 | 3.18 | 0.916 | 2.004 | 1.815 | 1.847 | 1.642 | 1.268 | 1.476 | 4.958 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 3.114 | 2.924 | 3.756 | 0.767 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 4.222 | 3.263 | 17.891 | 24.493 | 23.989 | 25.419 | 24.914 | 9.972 | 5.864 | -1.642 | -1.268 | -1.476 | 6.94 | 0 |
Other Current Liabilities
| 19.265 | 12.371 | 2.068 | 2.748 | 3.125 | 2.987 | 3.727 | 4.334 | 11.87 | 29.095 | 13.384 | 13.975 | 0.08 | 90.612 |
Total Current Liabilities
| 62.268 | 51.916 | 57.505 | 58.176 | 60.988 | 59.831 | 69.853 | 42.096 | 45.531 | 60.926 | 67.315 | 51.371 | 45.788 | 90.612 |
Non-Current Liabilities: | ||||||||||||||
Long Term Debt
| 6.886 | 1.921 | 6.705 | 1.359 | 3.987 | 1.018 | 0.94 | 2.959 | 4.79 | 6.667 | 0.459 | 1.145 | 2.613 | 1.794 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 1.556 | 1.344 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 2.47 | 4.207 | 0 | 0 | 0 | 0 | 0 | 2.116 | 1.698 | 2.169 | 2.103 |
Other Non-Current Liabilities
| 3.021 | 2.249 | 5.672 | 1.763 | 1.344 | 4.469 | 4.959 | 3.777 | 3.119 | 2.717 | 2.002 | 1.483 | 0 | 0 |
Total Non-Current Liabilities
| 9.907 | 4.17 | 12.377 | 7.148 | 10.882 | 5.487 | 5.899 | 6.736 | 7.909 | 9.384 | 4.577 | 4.326 | 4.782 | 3.897 |
Total Liabilities
| 72.175 | 56.086 | 69.882 | 65.324 | 71.87 | 65.318 | 75.752 | 48.832 | 53.44 | 70.31 | 71.892 | 55.697 | 50.57 | 94.509 |
Equity: | ||||||||||||||
Preferred Stock
| 0 | 576.322 | 545.945 | 526.498 | 896.426 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 | 207.963 |
Retained Earnings
| 135.692 | 116.945 | 86.568 | 67.121 | 51.441 | 40.796 | 46.23 | 39.746 | 35.472 | 34.464 | 54.272 | 53.882 | 0 | 0 |
Accumulated Other Comprehensive Income/Loss
| -0.977 | -0.528 | 0.141 | 0.469 | -383.861 | -397.114 | -367.821 | -337.48 | -307.657 | -270.424 | -223.602 | -188.961 | 0 | 0 |
Other Total Stockholders Equity
| 251.414 | -324.908 | -294.531 | -275.084 | -259.404 | 649.533 | 619.995 | 588.894 | 559.07 | 521.838 | 475.016 | 440.375 | 301.956 | 323.662 |
Total Shareholders Equity
| 594.092 | 575.794 | 546.086 | 526.967 | 512.565 | 501.178 | 506.367 | 499.123 | 494.848 | 493.841 | 513.649 | 513.259 | 509.919 | 531.625 |
Total Equity
| 594.092 | 575.794 | 546.086 | 526.967 | 512.565 | 501.178 | 506.367 | 499.123 | 494.848 | 493.841 | 513.649 | 513.259 | 509.919 | 531.625 |
Total Liabilities & Shareholders Equity
| 666.267 | 631.88 | 615.968 | 592.291 | 584.435 | 566.496 | 582.119 | 547.955 | 548.288 | 564.151 | 585.541 | 568.956 | 560.489 | 626.134 |